Bill SponsorBILLSPONSOR
Bill Sponsor
Politicians
Bills
Senate Bill 417
116th Congress(2019-2020)
Changing the Culture of the FDA Act
Introduced
Introduced
Introduced in Senate on Feb 7, 2019
Overview
Text
Introduced in Senate 
Feb 7, 2019
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in Senate(Feb 7, 2019)
Feb 7, 2019
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
S. 417 (Introduced-in-Senate)


116th CONGRESS
1st Session
S. 417


To direct the Secretary of Health and Human Services to amend the mission statement of the Food and Drug Administration.

IN THE SENATE OF THE UNITED STATES

February 7, 2019

Mr. Manchin introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions

A BILL

To direct the Secretary of Health and Human Services to amend the mission statement of the Food and Drug Administration.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Changing the Culture of the FDA Act”.

SEC. 2. Mission Statement of the Food and Drug Administration.

The Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, shall amend the mission statement of the Food and Drug Administration to include the following statement: “The FDA is also responsible for protecting the public health by strongly considering the danger of addiction and overdose death associated with prescription opioid medications when approving these medications and when regulating the manufacturing, marketing, and distribution of opioid medications.”.